168 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TSRO TESARO, Inc. $60.74 $3.3B Downtrend
Article Searches
Your Daily Pharma Scoop: Clovis Oncology Gets A Boost, Mesoblast Positive Data, Kadmon's Updated Results https://seekingalpha.com/article/4150177-daily-pharma-scoop-clovis-oncology-gets-boost-mesoblast-positive-data-kadmons-updated-results?source=feed_sector_healthcare Feb 24, 2018 - Clovis Oncology rose sharply this week on positive news from Europe.Mesoblast announced positive data from a phase 3 study evaluating MSC-100-IV.Kadmon provided updated results from a phase 2 study ev
NF Trinity Capital (Hong Kong) Ltd Buys JD. ... http://www.gurufocus.com/news/636007/nf-trinity-capital-hong-kong-ltd-buys-jdcom-inc-nxp-semiconductors-nv-the-priceline-group-inc-sells-spdr-select-sector-fund--health-care-mastercard-inc-global-blood-therapeutics-inc Feb 06, 2018 - NF Trinity Capital (Hong Kong) Ltd Buys JD.com Inc, NXP Semiconductors NV, The Priceline Group Inc, Sells SPDR Select Sector Fund - Health Care, Mastercard Inc, Global Blood Therapeutics Inc, Stocks: JD,NXPI,IBB,TSRO,CELG,PCLN,TMO,APLS,FNSR,ADSK,PANW, release date:Feb 06, 2018
Biotech Forum Daily Digest For February 3rd https://seekingalpha.com/article/4142881-biotech-forum-daily-digest-february-3rd?source=feed_sector_healthcare Feb 03, 2018 - The biotech sector is plummeting with the rest of the market this week trapped within a 'hiccup' that hits equities from time to time. The sector is basically given back last week's large gains and th
Buy Clovis Oncology Ahead Of Catalysts https://seekingalpha.com/article/4142453-buy-clovis-oncology-ahead-catalysts?source=feed_sector_healthcare Feb 01, 2018 - Clovis Oncology shares have struggled since the second half of 2017.Recent pullback due to competition concerns.Upcoming catalysts could boost stock price.
Vanguard Health Care Fund Buys Danaher, CVS Health, Adds to Allergan http://www.gurufocus.com/news/633587/vanguard-health-care-fund-buys-danaher-cvs-health-adds-to-allergan Feb 01, 2018 - Vanguard Health Care Fund Buys Danaher, CVS Health, Adds to Allergan, Stocks: DHR,AGN,CVS,IQV,TSRO,4523.JAPAN,TEVA,NKTR,ARE, Vanguard Health Care Fund, release date:Feb 01, 2018
Vanguard Health Care Fund Buys Danaher Corp, CVS Health Corp, IQVIA Holdings Inc, Sells Becton, ... http://www.gurufocus.com/news/632979/vanguard-health-care-fund-buys-danaher-corp-cvs-health-corp-iqvia-holdings-inc-sells-becton-dickinson-and-co-olympus-corp-intuitive-surgical-inc Jan 31, 2018 - Vanguard Health Care Fund Buys Danaher Corp, CVS Health Corp, IQVIA Holdings Inc, Sells Becton, Dickinson and Co, Olympus Corp, Intuitive Surgical Inc, Stocks: TSRO,GEN,ACHC,IDIA,DHR,CVS,IQV,NKTR,ARE,EW,ISRG,XR, release date:Jan 31, 2018
Biotech Forum Daily Digest For January 29th https://seekingalpha.com/article/4140911-biotech-forum-daily-digest-january-29th?source=feed_sector_healthcare Jan 29, 2018 - Biotech just had one of best weeks in recent memory and we have another acquisition this morning to report.It is a light week on the FDA calendar but Verastem could be on the move today thanks to a la
Biotech Forum Daily Digest For January 24th https://seekingalpha.com/article/4139699-biotech-forum-daily-digest-january-24th?source=feed_sector_healthcare Jan 24, 2018 - Biotech has surged this week on increased buyout speculation after two big deals were announced on Monday. Many firms are taking advantage of this rally by announcing secondary offerings.  Puma Biotec
Is Zejula A Flawed PARP Inhibitor? https://seekingalpha.com/article/4139575-zejula-flawed-parp-inhibitor?source=feed_tag_short_ideas Jan 23, 2018 - Tesaro is now a one-trick Zejula pony.Zejula's efficacy is similar or inferior to Rubraca/Lynparza.Like Varubi, Zejula has safety issues.After a 65% beating, short-term technicals may favor a rebound,
Your first trade for Tuesday, January 23 https://www.cnbc.com/2018/01/23/your-first-trade-for-tuesday-january-23.html Jan 23, 2018 - The "Fast Money" traders share their first moves for the market open.

Pages: 123456...17

Page 1>

Related Companies

Name Exchange Price Mkt Cap
LGND Ligand Pharmaceuticals Incorporated NASDAQ $153.81 $3.25B
LOXO Loxo Oncology, Inc. NASDAQ $113.91 $3.41B
PTLA Portola Pharmaceuticals, Inc. NASDAQ $45.82 $2.99B
GWPH GW Pharmaceuticals Plc NASDAQ $115.31 $2.93B
GBT Global Blood Therapeutics, Inc. NASDAQ $62.85 $2.91B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for TESARO
TSRO - Google Finance https://www.google.com/finance?q=TSRO Industry related info and international coverage Summary News
TSRO - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=TSRO Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options